Mayuka Tameishi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum Stress

Binding Protein

Endometrial Cancer

Top Venues

Journal of clinical medicine

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Rina Doukuni, Takuro Kobori, Chihiro Tanaka, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells. Journal of clinical medicine 11 (13) (2022)
Mayuka Tameishi, Honami Ishikawa, Chihiro Tanaka, Takuro Kobori, Yoko Urashima, Takuya Ito, Tokio Obata
Ezrin Contributes to the Plasma Membrane Expression of PD-L1 in A2780 Cells. Journal of clinical medicine 11 (9) (2022)
Chihiro Tanaka, Takuro Kobori, Rie Okada, Rina Doukuni, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Nobumasa Takagaki, Tokio Obata
Ezrin Regulates the Cell Surface Localization of PD-L1 in HEC-151 Cells. Journal of clinical medicine 11 (8) (2022)
Takuro Kobori, Chihiro Tanaka, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Mayuka Tameishi, Takuro Kobori, Chihiro Tanaka, Yoko Urashima, Takuya Ito, Tokio Obata
Contribution of Ezrin on the Cell Surface Plasma Membrane Localization of Programmed Cell Death Ligand-1 in Human Choriocarcinoma JEG-3 Cells. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Chihiro Tanaka, Takuro Kobori, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules (Basel, Switzerland) 26 (18) (2021)